Psychosocial factors in adults with chronic kidney disease: characteristics of pilot participants in the Tasmanian Chronic Kidney Disease study

Table 2 Baseline descriptive statistics for health-related quality of life measures (KDQOL-SF 1.3 and EQ-5D), the Tasmanian Chronic Kidney Disease study

Variable
Kidney disease-targeted scales	(mean ± SD) [range]^
Burden of kidney disease	71.9 ± 27.0 [6.3–100.0]
Quality of social interaction	80.3 ± 19.2 [26.7–100.0]
Cognitive function	84.1 ± 21.3 [0.0–100.0]
Symptoms/problems	76.1 ± 15.7 [31.8–100.0]
Effects of kidney disease	86.3 ± 16.4 [14.3–100.0]
Sexual function	65.9 ± 37.1 [0.0–100.0]
Sleep	63.2 ± 20.0 [5.0–95.0]
Social support	87.4 ± 21.1 [0.0–100.0]
Work status	33.7 ± 31.3 [0.0–100.0]
Overall health rating	64.5 ± 19.6 [20.0–100.0]
SF-36 scales
Physical Functioning	52.1 ± 29.6 [0.0–100.0]
Role limitations-physical	42.7 ± 41.9 [0.0–100.0]
Pain	66.1 ± 31.2 [0.0–100.0]
General health	43.8 ± 21.2 [0.0–85.0]
Emotional well-being	76.6 ± 20.3 [8.0–100.0]
Role limitations-emotional	63.2 ± 42.0 [0.0–100.0]
Social function	79.6 ± 25.9 [0.0–100.0]
Energy/fatigue	47.7 ± 24.5 [5.0–90.0]
SF-36 PCS	37.7 ± 10.1 [17.5–55.1]
SF-36 MCS	50.7 ± 9.4 [19.1–64.1]
EQ-5D	% reporting problems
Mobility	51.0
Self-care	12.2
Usual activities	49.0
Pain/discomfort	61.2
Anxiety/depression	26.5

^No participants were receiving dialysis at time of enrolment so ‘Staff encouragement’ and ‘Patient satisfaction’ scales were not completed.

ISSN: 1471-2369